<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19446" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Recurrent Pyogenic Cholangitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Arav</given-names>
          </name>
          <aff>University of Cambridge</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Simo</surname>
            <given-names>Kerri</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arav Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kerri Simo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19446.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Recurrent pyogenic cholangitis describes a chronic infective process of the biliary tree, presenting primarily with recurrent attacks of acute bacterial cholangitis. This disease is traditionally prevalent in Southeast Asia; however, due partly to global population migration, it can also be seen in North America and Europe. Due to its significant clinical overlap with other, more common types of cholangitis, it must be considered a differential diagnosis where relevant. This activity outlines the evaluation and treatment of recurrent pyogenic cholangitis and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the pathophysiology of recurrent pyogenic cholangitis.</p></list-item><list-item><p>Assess&#x000a0;typical presentation of a patient with recurrent pyogenic cholangitis.</p></list-item><list-item><p>Evaluate&#x000a0;management considerations for a patient with recurrent pyogenic cholangitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19446&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19446">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19446.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Recurrent pyogenic cholangitis (RPC) is a condition resulting from repeated infections of the biliary tree (cholangitis) first described in Hong Kong in 1930.<xref ref-type="bibr" rid="article-19446.r1">[1]</xref>&#x000a0;It can also be referred to as Oriental cholangiohepatitis, Hong Kong disease, Oriental infestation cholangitis, or hepatolithiasis.<xref ref-type="bibr" rid="article-19446.r2">[2]</xref>&#x000a0;Endemic to Southeast Asia, this disease is now seen worldwide due partly to increased population mobility and international travel. It is characterized by multiple intraductal calculi causing subsequent biliary tree dilatation and stricture.<xref ref-type="bibr" rid="article-19446.r3">[3]</xref>&#x000a0;Patients typically present with repeating episodes of acute cholangitis and, beyond immediate management, are at greater risk of complications than more common types of cholangitis due to the chronicity of the disease. Given its significant overlap in clinical presentation with other cholangitis causes, diagnosis of RPC is challenging. It requires a multidisciplinary approach, including the emergency physician, gastroenterologist, surgeon, interventional radiologist, and histopathologist, amongst other specialists. This&#x000a0;topic&#x000a0;seeks to review the etiology, epidemiology, and pathophysiology, outline the evaluation and treatment of pyogenic cholangitis and its potential complications and risks, and highlight the healthcare team's role in managing patients with this condition.</p>
      </sec>
      <sec id="article-19446.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>At the crux of this disease process is primary hepatolithiasis - the formation of multiple intraductal calculi without extrahepatic biliary obstruction. These are primarily brown-pigmented stones formed from calcium bilirubin, a product of increased rates of bilirubin deconjugation.<xref ref-type="bibr" rid="article-19446.r4">[4]</xref>&#x000a0;The exact etiology of this disequilibrium is unclear, and several mechanisms may play a part. Severe malnutrition is thought to result in deficiencies in enzymes such as D-Glucaro(1,4)lactone, an important beta-glucuronidase inhibitor responsible for inhibiting bilirubin deconjugation. With inhibition relatively unopposed, unconjugated bilirubin levels increase, leading to an increased propensity for calcium bilirubinate formation. Additionally, postulated is the role of helminthic infection.<xref ref-type="bibr" rid="article-19446.r5">[5]</xref><xref ref-type="bibr" rid="article-19446.r6">[6]</xref>&#x000a0;</p>
        <p>Chronic infection with common helminths such as Clonorchis sinensis and Ascaris lumbricoides are thought to induce biliary epithelial inflammation, reduce host immune response, and subsequently increase susceptibility to ascending infection from translocating gut pathogens such as <italic toggle="yes">E.coli</italic>, <italic toggle="yes">Proteus</italic>, and <italic toggle="yes">Klebsiella</italic>.<xref ref-type="bibr" rid="article-19446.r7">[7]</xref><xref ref-type="bibr" rid="article-19446.r8">[8]</xref>&#x000a0;Indeed, Ascaris ova have been observed at the center of calculi, suggesting a role in nidus formation. Both malnutrition and helminthic infection likely contribute to the strong association of&#x000a0;RPC with low socio-economic status. An association is increasingly less relevant as prevalent regions in East Asia improve their economies and access to healthcare. In summary,&#x000a0;RPC occurs due to hepatolithiasis, which stimulates a vicious cycle of recurrent bacterial infection, chronic epithelial damage, and ongoing biliary inflammation.<xref ref-type="bibr" rid="article-19446.r3">[3]</xref></p>
      </sec>
      <sec id="article-19446.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Specific statistics on worldwide rates of&#x000a0;RPC are scarce. It is rare in the United States and West (prevalence &#x0003c; 2%), and the incidence is highest in immigrant populations from East and Southeast Asia. Disease prevalence is reported as high as 30% in East Asian and Southeast Asian regions with endemic helminthic infection.<xref ref-type="bibr" rid="article-19446.r9">[9]</xref>&#x000a0;This has likely decreased in the 21st century with&#x000a0;higher access to healthcare, improved hygiene standards, and Westernization of diets. This disease affects women more than men, with&#x000a0;increasing age beyond 50 years a risk factor.&#x000a0;In one Korean study, the mean age of a patient at diagnosis was 59 years, with 71% of patients being female and 29% being men. Intrahepatic duct stones were present in 82% of cases in this study.<xref ref-type="bibr" rid="article-19446.r10">[10]</xref>&#x000a0;Data from Taiwan suggest that intrahepatic bile duct stones could be higher than 50%.<xref ref-type="bibr" rid="article-19446.r11">[11]</xref>&#x000a0;In 70% of those cases, there was the coexistence of intra and extrahepatic stones. These stones, made primarily of calcium bilirubinate, are responsible for developing RPC.<xref ref-type="bibr" rid="article-19446.r12">[12]</xref></p>
      </sec>
      <sec id="article-19446.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>RPC is primarily characterized by hepatolithiasis within the intrahepatic and extrahepatic bile ducts. These calculi, formed mostly by calcium bilirubinate, do not necessarily cause biliary obstruction (unlike cholesterol stones implicated in biliary colic) but initiate a cycle of inflammation and biliary stricture formation within&#x000a0;a dilated biliary tree. This in itself exposes the biliary tree to ascending translocation of mainly coliform bacteria from the gut (such as <italic toggle="yes">E.coli</italic>), the process of which is responsible for the acute-on-chronic cholangitis presentation that RPC is known. The role of helminthic infection is unclear, but it is thought that chronic infection with trematodes such as <italic toggle="yes">Clonorchis sinensis</italic> and nematodes such as Ascaris lumbricoides aid the inflammatory process and dampen the immune response, allowing for further bacterial translocation, epithelial fibrosis and scarring, and subsequent stricture formation.<xref ref-type="bibr" rid="article-19446.r13">[13]</xref></p>
      </sec>
      <sec id="article-19446.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>One study examining autopsy findings of 46 patients who died of&#x000a0;RPC&#x000a0;showed the presence of either biliary sludge or brown pigment stones in every case. 80% showed evidence of liver abscesses, a common complication of chronic pyogenic cholangitis. Early histological findings included portal inflammation and pylephlebitis, whereas later findings included periductal fibrosis and stricturing.<xref ref-type="bibr" rid="article-19446.r14">[14]</xref>&#x000a0;The occasionally observed presence of liver fluke ova within brown pigment stones suggests that helminthic infestation may play a role in lithogenesis.<xref ref-type="bibr" rid="article-19446.r5">[5]</xref></p>
      </sec>
      <sec id="article-19446.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with&#x000a0;RPC typically present on a spectrum of severity, ranging from mild symptoms in primary care to fulminant abdominal sepsis in the emergency department. Patients most often present with acute cholangitis, the symptoms of which include fevers, rigors, jaundice, vomiting, generalized abdominal pain, malaise, and pruritus. Charcot&#x02019;s triad of fever, jaundice, and right upper quadrant pain is common but not always seen in its entirety. Recurrent similar presentations of acute cholangitis may be apparent, and patients may report a history of past biliary drainage procedures or endoscopic retrograde cholangiopancreatography (ERCP). Patients may also report being from or having lived in Southeast and East Asian endemic regions, such as Taiwan, Hong Kong, or Japan. Therefore, it is important to take a careful social history.&#x000a0;</p>
        <p>During the later stages of the disease, patients may present with symptoms associated with complications of pyogenic cholangitis. For example, acute pancreatitis results in central rather than&#x000a0;right upper quadrant pain, and bile duct perforation may result in an acute, peritonitic abdomen. In the case of cholangiocarcinoma, patients might present cachectic and malaised, reporting a history of weight loss and other constitutional symptoms.</p>
      </sec>
      <sec id="article-19446.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A range of routine and specialized tests should aid clinicians in diagnosing RPC. These should be supported with careful history taking and comprehensive patient examination. Bloodwork should include a complete blood count, renal and liver function, coagulation studies, serum lipase, and peripheral blood cultures. The complete blood count may reveal microcytic anemia of chronic disease and neutrophilia. Raised urea and creatinine may be seen in more unwell, septic patients. Importantly, liver function tests&#x000a0;are likely deranged with values consistent with obstructive pathology, namely raised gamma-glutamyl transferase, alkaline phosphatase, and bilirubin.<xref ref-type="bibr" rid="article-19446.r15">[15]</xref>&#x000a0;Blood cultures may grow common gut pathogens such as <italic toggle="yes">E.coli</italic>.&#x000a0;Imaging has a major role in disease evaluation. Ultrasonography is the first-line bedside investigation of choice. Abdominal ultrasound in patients with PRC may show intrahepatic and extrahepatic biliary tree dilatation, more prominent in central than peripheral zones. Intraductal calculi may be visible; however, echogenicity is variable. Associated periportal echogenicity is often present.<xref ref-type="bibr" rid="article-19446.r16">[16]</xref>&#x000a0;Ultrasound is also useful for evaluating other findings consistent with more common diagnoses, such as a thickened gallbladder wall more consistent with acute cholecystitis, making&#x000a0;diagnosing RPC&#x000a0;less likely. However, a confusing picture can be seen with intrahepatic ductal dilatation but no extrahepatic ductal dilatation.</p>
        <p>Abdominal computed tomography provides information similar to ultrasound, with the added benefit of less user dependence and more clearly visualizing other abdominal structures and associated potential pathologies. Computed tomography findings include intrahepatic and extrahepatic biliary tree dilatation (central &#x0003e; peripheral zones), hyperdense intraductal calculi (especially on unenhanced scans), biliary wall thickening, biliary stricture, and, in rarer cases, pneumobilia. Patients with later-stage disease may demonstrate hepatic parenchymal atrophy, most commonly in the left lateral segment. Magnetic resonance cholangiopancreatography is the gold standard non-invasive imaging modality for diagnosing RPC.<xref ref-type="bibr" rid="article-19446.r17">[17]</xref>&#x000a0;In addition to picking up the aforementioned findings, magnetic resonance cholangiopancreatography is superior to computed tomography or sonography in the visualization of intraductal calculi and bile duct strictures characteristic of pyogenic cholangitis. The &#x0201c;arrowhead sign&#x0201d; refers to a finding of reduced arborization of the peripheral biliary tree. A subtle cholangiocarcinoma could also be appreciated.&#x000a0;Endoscopic retrograde cholangiopancreatography is an invasive procedure useful in diagnosing and managing RPC. It&#x000a0;is covered under &#x0201c;Treatment/Management.&#x0201d;</p>
      </sec>
      <sec id="article-19446.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of&#x000a0;RPC requires a multidisciplinary approach involving emergency physicians, interventional radiologists, gastroenterologists, surgeons (general or hepatobiliary), and allied health professionals at each stage of treatment. Patients presenting acutely should be managed using a resuscitative A to E approach. This likely involves oxygen therapy, fluid resuscitation, correction of potential coagulopathy, and initiation of broad-spectrum antibiotics. Critical care support in fulminant sepsis should be utilized. Definitive treatment of&#x000a0;RPC for those who do not respond to medical management comes in the form of biliary decompression. Initially, endoscopic retrograde cholangiopancreatography is used both to characterize the extent of disease (biliary tree &#x02018;mapping&#x02019; for future procedures) and to provide therapy eg stone removal, sphincterotomy, or stent insertion for visible and accessible strictures for more distal obstructions. Percutaneous transhepatic cholangiography (PTC)&#x000a0;is better for more peripherally obstructed ducts.<xref ref-type="bibr" rid="article-19446.r18">[18]</xref>&#x000a0;This decompression&#x000a0;can buy time while further definitive management is planned, as it alone may not be sufficient due to extensive stone burden and stricture formation. If the disease is anatomically limited (typically to the left lobe), surgical resection of the involved liver, as well as the extrahepatic bile with reconstruction, should be undertaken.</p>
        <p>Decompressive procedures may be required multiple times, and endoscopic ultrasound-guided drainage may be warranted, especially in those with concomitant hepatic abscesses, if surgical resection is not able to be performed.<xref ref-type="bibr" rid="article-19446.r19">[19]</xref> Therefore, in patients with extensive common bile duct and common hepatic duct stricture formation, surgical anastomoses such as choledochoduodenostomy or hepaticojejunostomy may be indicated with the creation of an access loop for future biliary procedures. In severe cases where extensive hepatic parenchymal destruction or multiple abscesses are present or in the presence of cholangiocarcinoma, a partial hepatectomy may be considered.&#x000a0;In these cases, cholecystectomy is often performed.&#x000a0;One single-center study in India examined surgical outcomes in 94 patients with RPC.<xref ref-type="bibr" rid="article-19446.r20">[20]</xref>&#x000a0;Eighty-three percent&#x000a0;of those who underwent primary surgery were deemed stone-free, with 81% remaining stone-free at a 3-year follow-up.&#x000a0;Eleven percent of patients had disease recurrence.&#x000a0;Another retrospective North American study of 42 patients with&#x000a0;RPC over twenty years showed a reduced disease recurrence in patients who had undergone surgery (hepatectomies or bile duct explorations with or without access loop formation) when compared with nonoperative patients (15% compared to 36% respectively).<xref ref-type="bibr" rid="article-19446.r21">[21]</xref>&#x000a0;Major abdominal surgery is high-risk, and decisions about whether to operate should be taken using an interprofessional approach. Additionally, in very rare cases, a liver transplant could be considered in a case of diffuse bilateral disease.<xref ref-type="bibr" rid="article-19446.r18">[18]</xref></p>
      </sec>
      <sec id="article-19446.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for recurrent pyogenic cholangitis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cholangitis (acute ascending cholangitis)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Primary sclerosing cholangitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cholecystitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Choledocholithiasis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Liver abscess (or pyogenic liver abscess)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pancreatitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Acute hepatitis</p>
          </list-item>
          <list-item>
            <p>Decompensated liver failure</p>
          </list-item>
          <list-item>
            <p>Cholangiocarcinoma&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Biliary helminthiasis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Anastomotic stricture after biliary tract surgery</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19446.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Cholangiocarcinoma is a recognized complication of RPC. One retrospective study from Hong Kong sought to explore whether a cholangiocarcinoma diagnosis on an RPC background carried a worse prognostic outcome than cholangiocarcinoma without associated RPC.<xref ref-type="bibr" rid="article-19446.r22">[22]</xref>&#x000a0;Propensity score matching was used to compare post-hepatectomy outcomes in cholangiocarcinoma patients with and without a diagnosis of pyogenic cholangitis (n=143). It was found that a&#x000a0;history of pyogenic cholangitis carried a significantly worse outcome for both disease-free survival and overall survival in this patient group.</p>
      </sec>
      <sec id="article-19446.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Retrospective studies suggest that disease recurrence is common despite attempts at definitive treatment.<xref ref-type="bibr" rid="article-19446.r23">[23]</xref>&#x000a0;Some of the best outcomes for&#x000a0;RPC are in patients who underwent hepatectomy as part of their treatment.<xref ref-type="bibr" rid="article-19446.r24">[24]</xref>&#x000a0;One study observed stone recurrence in long-term follow-ups in 31% of patients, and cholangiocarcinoma was observed in 5%.<xref ref-type="bibr" rid="article-19446.r25">[25]</xref>&#x000a0;Twenty percent of patients may eventually die from RPC&#x000a0;and its associated complications, some of which are often terminal.</p>
      </sec>
      <sec id="article-19446.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The complications that can manifest with RPC are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pancreatitis</p>
          </list-item>
          <list-item>
            <p>Acute kidney injury</p>
          </list-item>
          <list-item>
            <p>Septicemia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Disease recurrence&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Liver abscess (pyogenic)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Portal hypertension</p>
          </list-item>
          <list-item>
            <p>Secondary biliary cirrhosis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic liver disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cholangiocarcinoma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19446.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Knowledge of risk factors is important to reduce the risk of RPC. Patients from endemic regions should be educated about the symptoms and minimize modifiable risk factors, such as eating a nutritious and balanced diet to maintain a healthy weight. Liver fluke infections should be treated with antihelminthic drugs where appropriate to reduce the risk of chronic infection. Finally, patients diagnosed with&#x000a0;RPC should seek medical assistance early to avoid severe disease sequelae.</p>
      </sec>
      <sec id="article-19446.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>RPC is a rare form of cholangitis that presents very similarly to the more common acute ascending cholangitis. A careful history and attention to patient risk factors are critical to distinguishing the two. Histopathology and nuances in advanced imaging results also reveal valuable information that aids in diagnosing this uncommon disease.</p>
      </sec>
      <sec id="article-19446.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Although rare,&#x000a0;RPC can present acutely with symptoms in keeping with acute ascending cholangitis. When severe, patients can present in a life-threatening condition. Specific guidelines for managing acute RPC do not exist per se, but guidelines for the initial management of acute ascending cholangitis remain relevant, given the clinical overlap. Management bundles such as these facilitate a standard approach to the disease across sites, encourage optimized local protocols, and provide a framework within which a clinician can provide excellent patient care. The Tokyo Guidelines (2018) are a series of management bundles for acute cholangitis and cholecystitis. They include a helpful stepwise approach to managing acute cholangitis, taking into account the severity of presentation and providing guidance on when to consider drainage procedures and transfer to more specialist centers. Frameworks such as the Tokyo Guidelines can improve patient prognosis if used appropriately. Still, it is important to be aware that advanced management of pyogenic cholangitis does differ from acute ascending cholangitis, so these guidelines should be used with care and by appropriately trained clinicians.<xref ref-type="bibr" rid="article-19446.r26">[26]</xref><xref ref-type="bibr" rid="article-19446.r27">[27]</xref></p>
      </sec>
      <sec id="article-19446.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19446&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19446">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/recurrent-pyogenic-cholangitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19446">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19446/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19446">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19446.s18">
        <title>References</title>
        <ref id="article-19446.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verweij</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>van Buuren</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Oriental cholangiohepatitis (recurrent pyogenic cholangitis): a case series from the Netherlands and brief review of the literature.</article-title>
            <source>Neth J Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>74</volume>
            <issue>9</issue>
            <fpage>401</fpage>
            <page-range>401-405</page-range>
            <pub-id pub-id-type="pmid">27905307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castillo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Manterola</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grande</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rojas</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Infected hepatic echinococcosis. Clinical, therapeutic, and prognostic aspects. A systematic review.</article-title>
            <source>Ann Hepatol</source>
            <year>2021</year>
            <season>May-Jun</season>
            <volume>22</volume>
            <fpage>100237</fpage>
            <pub-id pub-id-type="pmid">32835861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwan</surname>
                <given-names>KEL</given-names>
              </name>
              <name>
                <surname>Shelat</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Recurrent pyogenic cholangitis: a review of imaging findings and clinical management.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-56</page-range>
            <pub-id pub-id-type="pmid">27770158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsui</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YW</given-names>
              </name>
            </person-group>
            <article-title>Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features.</article-title>
            <source>Semin Liver Dis</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-48</page-range>
            <pub-id pub-id-type="pmid">21344349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yellin</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Donovan</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Biliary lithiasis and helminthiasis.</article-title>
            <source>Am J Surg</source>
            <year>1981</year>
            <month>Jul</month>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>128</fpage>
            <page-range>128-36</page-range>
            <pub-id pub-id-type="pmid">7020457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Shelat</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Diddapur</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Oriental liver fluke infestation presenting more than 50 years after immigration.</article-title>
            <source>Ann Acad Med Singap</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>735</fpage>
            <page-range>735-6</page-range>
            <pub-id pub-id-type="pmid">19736582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaufman</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Magnuson</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Lillemoe</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Frasca</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pitt</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>The role of bacteria in gallbladder and common duct stone formation.</article-title>
            <source>Ann Surg</source>
            <year>1989</year>
            <month>May</month>
            <volume>209</volume>
            <issue>5</issue>
            <fpage>584</fpage>
            <page-range>584-91; discussion 591-2</page-range>
            <pub-id pub-id-type="pmid">2705823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ohto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsuchiya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saisho</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients.</article-title>
            <source>Dig Dis Sci</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-15</page-range>
            <pub-id pub-id-type="pmid">6365489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sakpal</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Babel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of hepatolithiasis.</article-title>
            <source>HPB (Oxford)</source>
            <year>2009</year>
            <month>May</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>194</fpage>
            <page-range>194-202</page-range>
            <pub-id pub-id-type="pmid">19590647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>You</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Paik</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.</article-title>
            <source>Gut Liver</source>
            <year>2019</year>
            <month>May</month>
            <day>15</day>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>373</fpage>
            <page-range>373-379</page-range>
            <pub-id pub-id-type="pmid">30600674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tazuma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic).</article-title>
            <source>Best Pract Res Clin Gastroenterol</source>
            <year>2006</year>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>1075</fpage>
            <page-range>1075-83</page-range>
            <pub-id pub-id-type="pmid">17127189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Sekijima</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Primary intrahepatic stones.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>90</volume>
            <issue>4</issue>
            <fpage>540</fpage>
            <page-range>540-8</page-range>
            <pub-id pub-id-type="pmid">7717308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daugherty</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Recurrent pyogenic cholangitis.</article-title>
            <source>Dig Dis Sci</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-10</page-range>
            <pub-id pub-id-type="pmid">19669879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chou</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Recurrent pyogenic cholangitis: a necropsy study.</article-title>
            <source>Pathology</source>
            <year>1980</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>415</fpage>
            <page-range>415-28</page-range>
            <pub-id pub-id-type="pmid">7432820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Virgile</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marathi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Cholangitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">32644372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afagh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pancu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Radiologic findings in recurrent pyogenic cholangitis.</article-title>
            <source>J Emerg Med</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-6</page-range>
            <pub-id pub-id-type="pmid">15028336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>MRCP findings in recurrent pyogenic cholangitis.</article-title>
            <source>Eur J Radiol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-83</page-range>
            <pub-id pub-id-type="pmid">17590555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeyarajah</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Recurrent Pyogenic Cholangitis.</article-title>
            <source>Curr Treat Options Gastroenterol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-98</page-range>
            <pub-id pub-id-type="pmid">15010022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chia</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Junnarkar</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Woon</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shelat</surname>
                <given-names>VG</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous drainage for giant pyogenic liver abscess--is it safe and sufficient?</article-title>
            <source>Am J Surg</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>211</volume>
            <issue>1</issue>
            <fpage>95</fpage>
            <page-range>95-101</page-range>
            <pub-id pub-id-type="pmid">26033361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sanyal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khamrui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chattopadhyyay</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Outcome of surgery for recurrent pyogenic cholangitis: a single center experience.</article-title>
            <source>HPB (Oxford)</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>10</issue>
            <fpage>821</fpage>
            <page-range>821-826</page-range>
            <pub-id pub-id-type="pmid">27506993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Sukhni</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gallinger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pratzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kortan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>McGilvray</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cattral</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Greig</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Recurrent pyogenic cholangitis with hepatolithiasis--the role of surgical therapy in North America.</article-title>
            <source>J Gastrointest Surg</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>496</fpage>
            <page-range>496-503</page-range>
            <pub-id pub-id-type="pmid">17999121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>She</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Chok</surname>
                <given-names>KSH</given-names>
              </name>
              <name>
                <surname>Yan Chan</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Chiu Dai</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Recurrent pyogenic cholangitis - an independent poor prognostic indicator for resectable intrahepatic cholangiocarcinoma: A propensity score matched analysis.</article-title>
            <source>HPB (Oxford)</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>20</volume>
            <issue>11</issue>
            <fpage>1067</fpage>
            <page-range>1067-1072</page-range>
            <pub-id pub-id-type="pmid">30017784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chijiiwa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuroki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current management and long-term prognosis of hepatolithiasis.</article-title>
            <source>Arch Surg</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>194</fpage>
            <page-range>194-7</page-range>
            <pub-id pub-id-type="pmid">7848091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Outcome of surgical treatment for recurrent pyogenic cholangitis: a single-centre study.</article-title>
            <source>HPB (Oxford)</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">19590627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheon</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YD</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis.</article-title>
            <source>Surgery</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>146</volume>
            <issue>5</issue>
            <fpage>843</fpage>
            <page-range>843-53</page-range>
            <pub-id pub-id-type="pmid">19744434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takada</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Tokyo Guidelines 2018: updated Tokyo Guidelines for the management of acute cholangitis/acute cholecystitis.</article-title>
            <source>J Hepatobiliary Pancreat Sci</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-2</page-range>
            <pub-id pub-id-type="pmid">29334699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19446.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayumi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Strasberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Solomkin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Schlossberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pitt</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gomi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miura</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garden</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Kiriyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yokoe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Asbun</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Iwashita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hibi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Umezawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Itoi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Dervenis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Asai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Belli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jagannath</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cherqui</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kozaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>de Santiba&#x000f1;es</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Higuchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gouma</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Deziel</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Liau</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Wakabayashi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Padbury</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Supe</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gabata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>ACW</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ker</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Kitano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inomata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Inui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sumiyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis.</article-title>
            <source>J Hepatobiliary Pancreat Sci</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-100</page-range>
            <pub-id pub-id-type="pmid">29090868</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
